NorthWest Biotherapeutics Inc (NWBO)

[pqr]

MI thanks for the earlier comment. I will disagree tho about a merger with CRL. NWBO Management IMO want to be separate for a lot of reasons but most of those boil down to normal corporate liability avoidance - preservation and protection of the principal assets of NWBO (IP and research capabilities) that again IMO are far more valuable than manufacturing capability which, even if bespoke, is replicable. I think this plan is shown in the Cognate contract history and you and I agree that apparently has been continued and adjusted as matters progress. And other breadcrumbs.